Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Carcinogenesis|November 12, 2019
REToma: a cancer subtype with a shared driver oncogeneTakashi Kohno, Junya Tabata, Takashi NakaokuCancer Science|September 3, 2013
RET fusion gene: translation to personalized lung cancer therapyTakashi Kohno, Koji Tsuta, Katsuya Tsuchihara, et al.Translational Lung Cancer Research|April 15, 2015
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancerTakashi Kohno, Takashi Nakaoku, Koji Tsuta, et al.Molecular and Clinical Oncology|March 24, 2015
Effect of liver toxicity on clinical outcome of patients with non-small-cell lung cancer treated with pemetrexedYuichi Sakamori, Young Hak Kim, Hironori Yoshida, et al.Cancer Research|February 4, 2016
Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine CircuitTakahiko Murayama, Takashi Nakaoku, Masato Enari, et al.Molecular and Clinical Oncology|June 23, 2016
Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancerHironori Yoshida, Young Hak Kim, Hiroaki Ozasa, et al.The Oncologist|February 8, 2017
An Oncogenic <i>ALK</i> Fusion and an <i>RRAS</i> Mutation in <i>KRAS</i> Mutation-Negative Pancreatic Ductal AdenocarcinomaYoko Shimada, Takashi Kohno, Hideki Ueno, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma TissuesKuniko Sunami, Koh Furuta, Koji Tsuta, et al.Cancer Research|September 27, 2022
Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive TumorigenesisJunya Tabata, Takashi Nakaoku, Mitsugu Araki, et al.Nature Communications|February 14, 2018
A secondary RET mutation in the activation loop conferring resistance to vandetanibTakashi Nakaoku, Takashi Kohno, Mitsugu Araki, et al.Pageof 2